Identification of the Aminoglycoside Resistance Determinants armA and rmtC among Non-Typhi Salmonella Isolates from Humans in the United States

Aminoglycosides are an important class of antimicrobial agents for the treatment of life-threatening bacterial infections. Several mechanisms for aminoglycoside resistance have been described previously (5). Among these mechanisms, 16S rRNA methyltransferases are especially troublesome due to their wide target range and their ability to confer high levels of resistance. In the United States, antimicrobial resistance among enteric pathogens in humans is monitored by the National Antimicrobial Resistance Monitoring System (NARMS) at the CDC. From 1996 to 2006, 18,281 non-Typhi Salmonella isolates were submitted to the CDC. MICs of 14 to 17 antimicrobial agents were determined by broth microdilution using the Sensititre system (Trek Diagnostics, Westlake, OH). Two isolates displayed resistance to three aminoglycosides, with resistance defined by a MIC of ≥64 μg/ml for amikacin, ≥16 μg/ml for gentamicin, and ≥64 μg/ml for kanamycin (Table ​(Table1). 1). Isolate AM04864 was Salmonella enterica serotype Stanley, submitted in 1999. Additional information from the patient was not available. AM23818 was S. enterica serotype Virchow, submitted in 2005. The patient was an 11-month-old Asian male from Hartford, CT. Prior to the onset of illness, he visited a farm in India and had exposure to farm animals. The patient became ill with nonbloody diarrhea in India. Upon returning to the United States, he was taken for medical care. Oral antibiotics were prescribed following specimen collection; the antibiotic name could not be recalled. The patient was ill with diarrhea for 6 weeks, during which he was presented for medical care two additional times. TABLE 1. Antimicrobial susceptibilities and characteristics of NARMS non-Typhi Salmonella isolates resistant to amikacin, gentamicin, and kanamycina Screening for methyltransferase genes was performed by PCR using previously described primers for six genes: armA, rmtA, rmtB, rmtC, rmtD, and npmA (2). AM04864 was positive for armA, while AM23818 was positive for rmtC. Sequence analysis confirmed that the armA gene was identical to that observed in Acinetobacter baumannii (GenBank accession number {"type":"entrez-nucleotide","attrs":{"text":"EU014811","term_id":"156105450","term_text":"EU014811"}}EU014811) and S. enterica serotype Oranienburg (GenBank accession number {"type":"entrez-nucleotide","attrs":{"text":"DQ177329","term_id":"74273694","term_text":"DQ177329"}}DQ177329). Sequence analysis also confirmed that armA was located between tnpU and tnpD, genes associated with the Tn1548 transposon (3, 4). Tn1548 typically carries additional genes which confer resistance to azithromycin, streptomycin-spectinomycin, sulfonamides, and trimethoprim. This may explain the additional resistance phenotype of AM04864 (Table ​(Table1). 1). Sequence analysis of the rmtC gene confirmed that the gene was identical to that observed in Proteus mirabilis (GenBank accession number {"type":"entrez-nucleotide","attrs":{"text":"EU144360","term_id":"160425359","term_text":"EU144360"}}EU144360) (7). To our knowledge, rmtC has not been identified outside of P. mirabilis. Upstream of the rmtC sequence, we identified the 3′ end of the ISEcp1 element, along with one of the inverted repeat regions. ISEcp1 has been shown previously to promote the expression and transposition of rmtC (6). Although ArmA is one of the most widespread methyltransferases in the world, it has been identified only in A. baumannii in the United States (1). RmtC has not previously been observed in the United States. All of the rmtC-positive isolates reported up to now have been P. mirabilis isolates from patients in Japan, with the exception of a single isolate from Australia (8). The patient infected with the Salmonella strain carrying the rmtC gene had recently traveled to India, suggesting that the infection originated in India. Identification of methyltransferase genes among non-Typhi Salmonella isolates from humans in the United States suggests the existence of a potential reservoir for these resistance mechanisms.